Moderna seeks approval for second COVID-19 booster shot for adults
If approved, this would be the second booster shot Moderna has issued for people ages 18 and up.
If approved, this would be the second booster shot Moderna has issued for people ages 18 and up.
Boosters are available to a much broader range of individuals, and that the types of vaccines people can get are more diverse.
The regulatory moves open the gate for boosters to be used more widely. In September, FDA authorized a booster for the Pfizer-BioNTech COVID-19 vaccine.
The recommendation applies to people 65 years and older, those 18 to 64 who are high risk of severe COVID and those people in the same age group whose work or institutional exposure puts them at high COVID risk.
The cases have been seen mostly in teens and young adults between 12 and 39 years old. No deaths have been associated with this side effect of the Pfizer and Moderna vaccines.
Results show 78.8% of the residents living at skilled nursing facilities have gotten shots.
Researchers hope to learn about the effectiveness of the vaccine for kids ages 6 months to less than 12 years old. Moderna plans to enroll roughly 6,750 children in eight U.S. states and Canada.
New guidance from the Centers for Disease Control and Prevention says that people fully vaccinated against COVID-19 can gather indoors in some circumstances but should keep wearing masks in public.
Around the U.S., politicians and school administrators have been pushing hard in recent weeks to reopen classrooms to stop students from falling behind and enable more parents to go back to work.